ES2074983T3 - Procedimieto para el aislamiento de proteinas de membranas basales a partir de tejidos humanos y animales. - Google Patents

Procedimieto para el aislamiento de proteinas de membranas basales a partir de tejidos humanos y animales.

Info

Publication number
ES2074983T3
ES2074983T3 ES88103668T ES88103668T ES2074983T3 ES 2074983 T3 ES2074983 T3 ES 2074983T3 ES 88103668 T ES88103668 T ES 88103668T ES 88103668 T ES88103668 T ES 88103668T ES 2074983 T3 ES2074983 T3 ES 2074983T3
Authority
ES
Spain
Prior art keywords
human
isolation
procedure
membrane proteins
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88103668T
Other languages
English (en)
Inventor
Dietrich Dr Brocks
Rupert Dr Timpl
Mats Dr Paulsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Original Assignee
Hoechst AG
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG, Max Planck Gesellschaft zur Foerderung der Wissenschaften eV filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2074983T3 publication Critical patent/ES2074983T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S261/00—Gas and liquid contact apparatus
    • Y10S261/88—Aroma dispensers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/803—Physical recovery methods, e.g. chromatography, grinding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/82—Subcellular parts of microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/961—Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • External Artificial Organs (AREA)
  • Shaping By String And By Release Of Stress In Plastics And The Like (AREA)
  • Tires In General (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LAS PROTEINAS BASALES DE MEMBRANA SE AISLAN, COMO PROTEINAS FUNCIONALES EN CANTIDADES RELATIVAMENTE GRANDES, A PARTIR DE TEJIDOS HUMANOS O ANIMALES EN SOLUCION ACUOSA EN PRESENCIS DE UN AGENTE DE QUELACION. CON AYUDA DE ESTAS PROTEINAS SE PUEDEN OBTENER ANTICUERPOS DE ALTA ESPECIFICIDAD QUE SE UTILIZN PARA LA DETERMINACION INMUNOLOGICA DE ESTAS PROTEINAS.
ES88103668T 1987-03-13 1988-03-09 Procedimieto para el aislamiento de proteinas de membranas basales a partir de tejidos humanos y animales. Expired - Lifetime ES2074983T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873708198 DE3708198A1 (de) 1987-03-13 1987-03-13 Verfahren zur isolierung von basalmembranproteinen aus menschlichen und tierischen geweben

Publications (1)

Publication Number Publication Date
ES2074983T3 true ES2074983T3 (es) 1995-10-01

Family

ID=6323001

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88103668T Expired - Lifetime ES2074983T3 (es) 1987-03-13 1988-03-09 Procedimieto para el aislamiento de proteinas de membranas basales a partir de tejidos humanos y animales.

Country Status (11)

Country Link
US (1) US5147782A (es)
EP (1) EP0282018B1 (es)
JP (1) JP2532559B2 (es)
AT (1) ATE124706T1 (es)
DE (2) DE3708198A1 (es)
DK (1) DK173677B1 (es)
ES (1) ES2074983T3 (es)
FI (1) FI99114C (es)
IE (1) IE67563B1 (es)
NO (1) NO173336C (es)
PT (1) PT86944B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5512657A (en) * 1988-12-12 1996-04-30 Bainbridge Sciences, Inc. Detection of complexes which include basement membrane components as diagnostic of cancer and other diseases
US5541076A (en) * 1988-12-12 1996-07-30 Bard Diagnostic Sciences, Inc. Methods for determining the invasiveness of a bladder tumor
CA2109088A1 (en) * 1991-04-26 1992-10-27 Emanuel Calenoff Methods to detect and treat diseases caused by bacterial allergens
NZ524868A (en) 2003-03-21 2005-09-30 Velvet Antler Res New Zealand Process for purifying low molecular weight proteins from tissue in situ
NZ526157A (en) * 2003-05-27 2006-01-27 Velvet Antler Res New Zealand Method for the extraction of deer antler and use of the extract therefrom
US20070190165A1 (en) * 2005-10-21 2007-08-16 Brey Eric M Tissue-specific basement membrane gels
WO2013162828A1 (en) 2012-04-27 2013-10-31 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Use of cpg oligonucleotides co-formulated with an antibiotic to accelarate wound healing
AR131080A1 (es) * 2022-12-21 2025-02-12 Cristalia Produtos Quim Farmaceuticos Ltda Procesos de extracción, purificación y polimerización de laminina, uso, polilaminina y kit

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2923583A1 (de) * 1979-06-11 1980-12-18 Max Planck Gesellschaft Verfahren zur immunologischen bestimmung von basalmembranmaterial und hierfuer geeignete neue basalmembranfragmente
US4628027A (en) * 1982-05-19 1986-12-09 Molecular Engineering Associates, Ltd. Vitro diagnostic methods using monoclonal antibodies against connective tissue proteins
DE3511199A1 (de) * 1985-03-28 1986-10-02 Hoechst Ag, 6230 Frankfurt Verfahren zur immunologischen bestimmung von heparansulfat-proteoglykan, verfahren zur herstellung bzw. reinigung von dafuer geeignetem heparansulfat-proteoglykan aus basalmembran-haltigen geweben
JPH01155757A (ja) * 1987-12-11 1989-06-19 Nec Corp 可変不在転送解除方式

Also Published As

Publication number Publication date
FI881122L (fi) 1988-09-14
DK173677B1 (da) 2001-06-11
NO173336B (no) 1993-08-23
DK135688D0 (da) 1988-03-11
NO173336C (no) 1993-12-01
NO881111L (no) 1988-09-14
EP0282018B1 (de) 1995-07-05
DK135688A (da) 1988-09-14
EP0282018A2 (de) 1988-09-14
FI881122A0 (fi) 1988-03-10
IE67563B1 (en) 1996-04-17
ATE124706T1 (de) 1995-07-15
DE3854096D1 (de) 1995-08-10
FI99114B (fi) 1997-06-30
JP2532559B2 (ja) 1996-09-11
IE880729L (en) 1988-09-13
NO881111D0 (no) 1988-03-11
JPS63243098A (ja) 1988-10-07
US5147782A (en) 1992-09-15
FI99114C (fi) 1997-10-10
PT86944B (pt) 1992-05-29
EP0282018A3 (en) 1990-01-24
DE3708198A1 (de) 1988-09-22
PT86944A (pt) 1988-04-01

Similar Documents

Publication Publication Date Title
MX9306220A (es) Ptp 1d: una proteina tirosina fosfatasa novedosa.
ES2177964T3 (es) Procedimiento de produccion de celulas t activadas marcadas especificas de tumores y su uso para el tratamiento de tumores.
ES2153444T3 (es) Anticuerpos contra interleucina-4 mamifera, y peptidos utiles como antigenos en su produccion.
ES2151607T3 (es) Factor 12 de crecimiento y de diferenciacion.
SE8504872D0 (sv) Selekteringsforfarande och medel herfor
ES2051705T3 (es) Preparados con contenido de acidos grasos insaturados para la sintesis de prostaglandinas e hidroxi-acidos grasos en sistemas biologicos.
SE7600284L (sv) Terapeutisk insulinberedning.
NO904023L (no) Blanding som induserer binding.
KR900002795A (ko) 하이브리드 단백질c 작제물 및 그들의 제조방법
ES2038969T3 (es) Procedimiento para la renaturalizacion de proteinas.
SE8703064D0 (sv) Method for isolating active enzyme preparations from animal tissues
Clements et al. Protease in ammocoetes endostyle
ATE48142T1 (de) Blutprotein, verfahren zu seiner herstellung, antikoerper gegen dieses protein und dieses protein oder diese antikoerper enthaltende pharmazeutische zubereitungen.
FI99114B (fi) Menetelmä tyvikalvoproteiinien eristämiseksi ihmis- ja eläinkudoksista
NO912621D0 (no) Fremgangsmaate for innfoering av dna i animalske celler.
PT86552A (de) Gama-glutamyl-transpeptidase deren herstellung und deren verwendung
ES2077674T3 (es) Aumento de la produccion de proteinas en animales.
ES2064336T3 (es) Procedimiento para la preparacion de proteinas.
Heller et al. Antigenicity of connective tissue extracts.
SCHWARTZ et al. Growth hormone covalently bound to Sepharose. II. Study of the biological activity of a growth hormone—Sepharose complex in adipose tissue and diaphragm muscle
DE3883044D1 (de) Wirkstoff zur tumorbekaempfung.
Ouaissi et al. Occurrence of fibronectin antigenic determinants on Schistosoma mansoni lung schistosomula and adult worms
BG100921A (bg) Средство и метод за лечение на автоимунни заболявания
GB2003887A (en) Isolation of peptides from urine
ES469908A1 (es) Procedimiento de utilizacion de salinomicina.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 282018

Country of ref document: ES